These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4359 related articles for article (PubMed ID: 6132488)

  • 1. DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course.
    Søndergaard K; Larsen JK; Møller U; Christensen IJ; Hou-Jensen K
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 42(1):43-52. PubMed ID: 6132488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
    Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
    Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry.
    Winokur TS; Palazzo JP; Johnson WC; Duray PH
    J Cutan Pathol; 1990 Dec; 17(6):342-7. PubMed ID: 2074280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
    Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
    Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology, morphometry, and nuclear DNA content of iris melanocytic lesions.
    Grossniklaus HE; Oakman JH; Cohen C; Calhoun FP; DeRose PB; Drews-Botsch C
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):745-50. PubMed ID: 7890505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small malignant melanomas: clinicopathologic correlation and DNA ploidy analysis.
    Kamino H; Kiryu H; Ratech H
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1032-8. PubMed ID: 2370327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma.
    Chi HI; Ishibashi Y; Shima A; Mihara I; Otsuka F
    J Invest Dermatol; 1990 Aug; 95(2):154-7. PubMed ID: 2380576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy and S-phase fraction in primary melanomas and their regional metastases.
    Karlsson M; Boeryd B; Carstensen J; Kågedal B; Wingren S
    Melanoma Res; 1994 Feb; 4(1):47-51. PubMed ID: 8032217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow DNA-cytometric findings of paraffin-embedded primary cutaneous melanomas related to prognosis.
    Lindholm C; Hofer PA; Jonsson H; Tribukait B
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):147-51. PubMed ID: 2575819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
    Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J
    Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis.
    Lindholm C; Hofer PA; Jonsson H
    Acta Oncol; 1990; 29(2):147-50. PubMed ID: 2334568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ploidy of malignant melanoma determined by image cytometry of fresh frozen and paraffin-embedded tissue.
    Herzberg AJ; Kerns BJ; Borowitz MJ; Seigler HF; Kinney RB
    J Cutan Pathol; 1991 Dec; 18(6):440-8. PubMed ID: 1774354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-ploidy abnormalities are a reflection of the metastatic potential of malignant melanoma. Microfluorometric DNA analysis.
    Umebayashi Y; Otsuka F
    Acta Derm Venereol; 1997 Mar; 77(2):118-21. PubMed ID: 9111821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy in thin melanoma.
    Zardawi IM; Jarvis L; Hersey P; Francis L; Shaw H; Grace J
    Pathology; 1988 Jul; 20(3):243-6. PubMed ID: 3205595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 218.